Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Linsitinib | 1 | uM | 7 | 1250.00 | 859.67 | 1859.00 | 1850.00 | 1.0049 | 1.0088 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 7 | 1250.00 | 859.67 | 1225.00 | 1850.00 | 0.6622 | 0.3776 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 7 | 1250.00 | 859.67 | 1986.00 | 1850.00 | 1.0735 | 1.1325 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 7 | 1250.00 | 859.67 | 791.00 | 1850.00 | 0.4276 | -0.0725 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 7 | 1250.00 | 859.67 | 1111.00 | 1850.00 | 0.6005 | 0.2611 |
| SK-BR-3 | Lapatinib | 1 | uM | 7 | 1250.00 | 859.67 | 428.00 | 1850.00 | 0.2314 | -0.4678 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 7 | 1250.00 | 859.67 | 1836.00 | 1850.00 | 0.9924 | 0.9863 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 7 | 1250.00 | 859.67 | 1627.00 | 1850.00 | 0.8795 | 0.7807 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 7 | 1250.00 | 859.67 | 1004.00 | 1850.00 | 0.5427 | 0.1507 |
| SK-BR-3 | Erlotinib | 10 | uM | 7 | 1250.00 | 859.67 | 849.00 | 1850.00 | 0.4589 | -0.0112 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 7 | 1250.00 | 859.67 | 882.00 | 1850.00 | 0.4768 | 0.0235 |
| SK-BR-3 | 17-AAG | 0.0033113 | uM | 7 | 1250.00 | 859.67 | 1338.00 | 1850.00 | 0.7232 | 0.4920 |
| SK-BR-3 | Lapatinib | 10 | uM | 7 | 1250.00 | 859.67 | 836.00 | 1850.00 | 0.4519 | -0.0249 |
| SK-BR-3 | 0 | uM | 7 | 1250.00 | 859.67 | 1608.00 | 1850.00 | 0.8692 | 0.7618 | |
| SK-BR-3 | 0 | uM | 7 | 1250.00 | 859.67 | 2.00 | 1850.00 | 0.0011 | -0.9959 | |
| SK-BR-3 | 0 | uM | 7 | 2500.00 | 1881.33 | 2.00 | 3839.00 | 0.0005 | -0.9987 | |
| SK-BR-3 | 0 | uM | 7 | 2500.00 | 1881.33 | 4086.00 | 3839.00 | 1.0643 | 1.1249 | |
| SK-BR-3 | Linsitinib | 0.01 | uM | 7 | 2500.00 | 1881.33 | 3822.00 | 3839.00 | 0.9956 | 0.9914 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 7 | 2500.00 | 1881.33 | 3771.00 | 3839.00 | 0.9823 | 0.9656 |
| SK-BR-3 | 0 | uM | 7 | 2500.00 | 1881.33 | 4036.00 | 3839.00 | 1.0513 | 1.0997 | |
| SK-BR-3 | 17-AAG | 1 | uM | 7 | 2500.00 | 1881.33 | 1752.00 | 3839.00 | 0.4564 | -0.0669 |
| SK-BR-3 | Linsitinib | 10 | uM | 7 | 2500.00 | 1881.33 | 3044.00 | 3839.00 | 0.7929 | 0.5962 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 7 | 2500.00 | 1881.33 | 1937.00 | 3839.00 | 0.5046 | 0.0287 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 7 | 2500.00 | 1881.33 | 3920.00 | 3839.00 | 1.0211 | 1.0410 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 7 | 2500.00 | 1881.33 | 2366.00 | 3839.00 | 0.6163 | 0.2495 |